If this email is not displayed correctly please click here

Healthcare & Life Sciences

14 October 2020
Elena Ramacciotti Patent implications of COVID-19 crisis: current solutions according to Italian law

Italy - Trevisan & Cuonzo

The current health emergency has highlighted the need to reconcile the urgency in offering a response to the spread of COVID-19 with the need to continue ensuring the effectiveness of patent protection. For this purpose, the Italian legal system offers a number of solutions based on legitimising the use of a pre-existing patent without the owner's consent on the one hand and guaranteeing the accessibility of patented inventions to the most people without having to deny the owner's exclusive rights on the other.

Author: Elena Ramacciotti
Read more

Recent updates

Daniel Kendziur Binding implications of notification under German Drug Act and qualification of preparation as presentation drug

Germany - Simmons & Simmons LLP

Authors: Daniel Kendziur, Fabian Huber
David Schwartz 8 important life sciences IP issues for innovators doing business in Canada

Canada - Smart & Biggar

Author: David Schwartz
Armand Aviges Suspension of decision granting Baclocur market authorisation when decision is based on compromise rather than scientific knowledge

France - Altana

Authors: Armand Aviges, Delphine Lapillonne
Amy de La Lama Telehealth privacy issues due to COVID-19

USA - Baker McKenzie

Author: Amy de La Lama
Petter Larsson Objective necessity to rebox in parallel trade and implementation of EU Falsified Medicines Regulation

Sweden - Westerberg & Partners Advokatbyrå Ab

Authors: Petter Larsson, Jonas Löfgren
Magdalena Kotyrba Intellectual property in clinical trials

European Union - Eversheds Sutherland (International) LLP

Authors: Magdalena Kotyrba, Tobias Maier